SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Amerinst Insurance Group Ltd – ‘10-Q’ for 9/30/19

On:  Wednesday, 11/13/19, at 4:55pm ET   ·   For:  9/30/19   ·   Accession #:  1193125-19-291100   ·   File #:  0-28249

Previous ‘10-Q’:  ‘10-Q’ on 8/12/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/13/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 11/15/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/13/19  Amerinst Insurance Group Ltd      10-Q        9/30/19   44:4.3M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    344K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
23: R1          Document And Entity Information                     HTML     43K 
41: R2          Condensed Consolidated Balance Sheets (Current      HTML     95K 
                Period Unaudited)                                                
31: R3          Condensed Consolidated Balance Sheets (Current      HTML     30K 
                Period Unaudited) (Parentheticals)                               
17: R4          Condensed Consolidated Statements of Operations,    HTML    106K 
                Comprehensive Income and Retained Earnings                       
                (Unaudited)                                                      
22: R5          Consolidated Statements of Changes in               HTML     64K 
                Shareholders' Equity (Unaudited)                                 
40: R6          Consolidated Statements of Changes in               HTML     18K 
                Shareholders' Equity (Unaudited) (Parentheticals)                
30: R7          Condensed Consolidated Statements of Cash Flows     HTML     54K 
                (Unaudited)                                                      
18: R8          Note 1 - Basis of Preparation and Consolidation     HTML     38K 
21: R9          Note 2 - Investments                                HTML    316K 
44: R10         Note 3 - Liability for Unpaid Losses and Loss       HTML     37K 
                Adjustment Expenses                                              
33: R11         Note 4 - Segment Information                        HTML     63K 
20: R12         Note 5 - Stock Compensation                         HTML     99K 
26: R13         Significant Accounting Policies (Policies)          HTML     39K 
43: R14         Note 2 - Investments (Tables)                       HTML    290K 
32: R15         Note 3 - Liability for Unpaid Losses and Loss       HTML     34K 
                Adjustment Expenses (Tables)                                     
19: R16         Note 4 - Segment Information (Tables)               HTML     62K 
25: R17         Note 5 - Stock Compensation (Tables)                HTML     89K 
42: R18         Note 2 - Investments (Details Textual)              HTML     29K 
34: R19         Note 2 - Investments - Cost or Amortized Cost,      HTML     40K 
                Gross Unrealized Holding Gains and Losses, and                   
                Estimated Fair Value of Fixed Maturity Investments               
                (Details)                                                        
13: R20         Note 2 - Investments - Fixed Maturity and           HTML     54K 
                Securities in an Unrealized Loss Position and                    
                Aggregate Fair Value and Gross Unrealized Loss                   
                (Details)                                                        
29: R21         Note 2 - Investments - Fair Value of Investments    HTML     43K 
                (Details)                                                        
39: R22         Note 2 - Investments - Cost or Amortized Cost and   HTML     39K 
                Estimated Fair Value of Fixed Maturity Investments               
                (Details)                                                        
37: R23         Note 2 - Investments - Sales and Maturities of      HTML     37K 
                Investments (Details)                                            
12: R24         Note 2 - Investments - Major Categories of Net      HTML     28K 
                Interest and Dividend Income (Details)                           
28: R25         Note 3 - Liability for Unpaid Losses and Loss       HTML     16K 
                Adjustment Expenses (Details Textual)                            
38: R26         Note 3 - Liability for Unpaid Losses and Loss       HTML     37K 
                Adjustment Expenses - Liability for Losses and                   
                Loss Adjustment Expense Activity (Details)                       
36: R27         Note 4 - Segment Information (Details Textual)      HTML     16K 
15: R28         Note 4 - Segment Information - Segment Reporting    HTML     39K 
                Information (Details)                                            
27: R29         Note 5 - Stock Compensation (Details Textual)       HTML     41K 
24: R30         Note 5 - Stock Compensation - Summary of the        HTML     80K 
                Status of the Stock Option Plan (Details)                        
14: XML         IDEA XML File -- Filing Summary                      XML     75K 
16: EXCEL       IDEA Workbook of Financial Reports                  XLSX     39K 
 6: EX-101.INS  XBRL Instance -- aigt-20190930                       XML   1.63M 
 8: EX-101.CAL  XBRL Calculations -- aigt-20190930_cal               XML     98K 
 9: EX-101.DEF  XBRL Definitions -- aigt-20190930_def                XML    517K 
10: EX-101.LAB  XBRL Labels -- aigt-20190930_lab                     XML    498K 
11: EX-101.PRE  XBRL Presentations -- aigt-20190930_pre              XML    562K 
 7: EX-101.SCH  XBRL Schema -- aigt-20190930                         XSD     86K 
35: ZIP         XBRL Zipped Folder -- 0001193125-19-291100-xbrl      Zip     93K 


‘10-Q’   —   Quarterly Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 10-Q  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

Quarterly report pursuant to section 13 or 15 (d) of the Securities Exchange Act of 1934

For the Quarterly Period ended September 30, 2019.

 

Transition report pursuant to section 13 or 15 (d) of the Securities Exchange Act of 1934.

For the transition period from                  to                 .

Commission file number 000-28249

 

 

AMERINST INSURANCE GROUP, LTD.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

BERMUDA   98-0207447

(State or other jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

c/o Citadel Management Bermuda Limited

25 Church Street, Continental Building

P.O. Box HM 1601, Hamilton, Bermuda

  HMGX
(Address of Principal Executive Offices)   (Zip Code)

(441) 295-6015

(Telephone number)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

                                          

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “accelerated filer,” “large accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
Emerging Growth Company       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of The Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES  ☐    NO  ☒.

Securities registered pursuant to Section 12(b) of the Act: None.

As of November 1, 2019, the Registrant had 995,253 common shares, $1.00 par value per share, outstanding.

 

 

 


Introductory Note

Caution Concerning Forward-Looking Statements

Certain statements contained in this Form 10-Q, or otherwise made by our officers, including statements related to our future performance, our outlook for our businesses and respective markets, projections, statements of our management’s plans or objectives, forecasts of market trends and other matters, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and contain information relating to us that is based on the beliefs of our management as well as assumptions made by, and information currently available to, our management. The words “expect,” “believe,” “may,” “could,” “should,” “would,” “estimate,” “anticipate,” “intend,” “plan,” “target,” “goal” and similar expressions as they relate to us or our management are intended to identify forward-looking statements. Such statements reflect our management’s current views with respect to future events and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially from those reflected in any forward-looking statements. Our actual future results may differ materially from those set forth in our forward-looking statements. Factors that might cause such actual results to differ materially from those reflected in any forward-looking statements include, but are not limited to the factors discussed in detail in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q, as well as:

 

   

our ability to generate increased revenues and positive earnings in future periods;

 

   

the occurrence of catastrophic events with a frequency or severity exceeding our expectations;

 

   

the legislative and administrative impact of the current United States administration on our business;

 

   

subjection of our non-U.S. companies to regulation and/or taxation in the United States;

 

   

a decrease in the level of demand for professional liability insurance and reinsurance or an increase in the supply of professional liability insurance and reinsurance capacity;

 

   

our ability to meet the performance goals and metrics set forth in our business plan without a significant depletion of our cash resources while maintaining sufficient capital levels;

 

   

the effects of security breaches, cyber-attacks or computer viruses that may affect our computer systems or those of our customers, third-party managers and service providers;

 

   

a worsening of the current global economic market conditions and changing rates of inflation and other economic conditions;

 

   

increased competitive pressures, including the consolidation and increased globalization of reinsurance providers;

 

   

actual losses and loss expenses exceeding our loss reserves, which are necessarily based on the actuarial and statistical projections of ultimate losses;

 

   

increased or decreased rate pressure on premiums;

 

   

adequacy of our risk management and loss limitation methods;

 

   

the successful integration of businesses we may acquire or new business ventures we may start;

 

   

acts of terrorism, political unrest, outbreak of war and other hostilities or other non-forecasted and unpredictable events;

 

   

compliance with and changes in the legal or regulatory environments in which we operate; and

 

   

other risks, including those risks identified in any of our other filings with the Securities and Exchange Commission.

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with other cautionary statements that are included herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect our management’s analysis only as of the date they are made. We undertake no obligation to release publicly the results of any future revisions we may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

2


Part I—FINANCIAL INFORMATION

 

Item 1.

Financial Statements.

AMERINST INSURANCE GROUP, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, expressed in U.S. dollars)

 

     As of
September 30,
2019
    As of
December 31,
2018
 

ASSETS

    

Investments:

    

Fixed maturity investments, at fair value (amortized cost $14,801,687 and $14,806,427)

   $ 14,918,441     $ 14,588,080  

Equity securities, at fair value (cost $12,002,872, and $12,145,120)

     15,914,233       13,445,226  
  

 

 

   

 

 

 

TOTAL INVESTMENTS

     30,832,674       28,033,306  

Cash and cash equivalents

     5,978,562       5,498,914  

Restricted cash and cash equivalents

     930,874       472,132  

Assumed reinsurance premiums receivables

     2,886,098       2,651,863  

Accrued investment income

     105,660       88,569  

Property and equipment

     983,448       776,382  

Deferred income taxes

     2,785,000       2,730,000  

Deferred policy acquisition costs

     2,111,128       1,869,368  

Prepaid expenses and other assets

     1,974,296       1,981,913  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 48,587,740     $ 44,102,447  
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

LIABILITIES

    

Unpaid losses and loss adjustment expenses

   $ 15,797,403     $ 12,989,260  

Unearned premiums

     5,705,725       5,051,847  

Assumed reinsurance payable

     1,077,067       2,171,767  

Accrued expenses and other liabilities

     5,764,045       5,934,408  
  

 

 

   

 

 

 

TOTAL LIABILITIES

   $ 28,344,240     $ 26,147,282  
  

 

 

   

 

 

 

COMMITMENTS AND CONTINGENCIES

    

SHAREHOLDERS’ EQUITY

    

Common shares, $1 par value, 2019 and 2018: 2,000,000 shares authorized, 995,253 issued and outstanding

   $ 995,253     $ 995,253  

Additional paid-in-capital

     6,444,036       6,393,730  

Retained earnings

     21,558,508       19,725,581  

Accumulated other comprehensive income

     116,754       (218,348

Shares held by Subsidiary (362,699 and 365,198 shares) at cost

     (8,871,051     (8,941,051
  

 

 

   

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

     20,243,500       17,955,165  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

   $ 48,587,740     $ 44,102,447  
  

 

 

   

 

 

 

 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

3


AMERINST INSURANCE GROUP, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF

OPERATIONS, COMPREHENSIVE INCOME

AND RETAINED EARNINGS

(Unaudited, expressed in U.S. dollars)

 

     Nine Months
Ended
September 30,
2019
    Nine Months
Ended
September 30,
2018
    Three Months
Ended
September 30,
2019
    Three Months
Ended
September 30,
2018
 

REVENUE

        

Net premiums earned

   $ 8,141,526     $ 7,224,922     $ 2,815,917     $ 2,554,044  

Commission income

     4,395,855       4,091,561       1,450,367       1,334,352  

Net investment income

     355,143       267,908       125,491       92,215  

Net realized and unrealized gains on investments

     2,595,789       895,340       72,492       567,054  
  

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL REVENUE

     15,488,313       12,479,731       4,464,267       4,547,665  
  

 

 

   

 

 

   

 

 

   

 

 

 

LOSSES AND EXPENSES

        

Losses and loss adjustment expenses

     5,210,575       4,660,077       1,802,187       1,647,362  

Policy acquisition costs

     3,012,548       2,673,143       1,041,890       944,994  

Operating and management expenses

     5,138,604       4,874,487       1,636,073       1,515,854  
  

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL LOSSES AND EXPENSES

     13,361,727       12,207,707       4,480,150       4,108,210  
  

 

 

   

 

 

   

 

 

   

 

 

 

NET INCOME (LOSS) BEFORE TAX

     2,126,586       272,024       (15,883     439,455  

Income tax (benefit) expense

     (32,032     —         6,654       —    

NET INCOME (LOSS) AFTER TAX

   $ 2,158,618     $ 272,024     $ (22,537   $ 439,455  
  

 

 

   

 

 

   

 

 

   

 

 

 

OTHER COMPREHENSIVE INCOME (LOSS)

        

Net unrealized holding gains (losses) arising during the period

     335,102       (207,907     68,341       (18,529

Reclassification adjustment for gains included in net income

     —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

 

OTHER COMPREHENSIVE INCOME (LOSS)

     335,102       (207,907     68,341       (18,529
  

 

 

   

 

 

   

 

 

   

 

 

 

COMPREHENSIVE INCOME

   $ 2,493,720     $ 64,117     $ 45,804     $ 420,926  
  

 

 

   

 

 

   

 

 

   

 

 

 

RETAINED EARNINGS, BEGINNING OF PERIOD

   $ 19,725,581     $ 15,812,419     $ 21,581,045     $ 20,424,521  

Net income (loss)

     2,158,618       272,024       (22,537     439,455  

Dividends

     (325,691     (313,417     —         —    

Cumulative effect of adoption of accounting guidance (ASU 2016-01)

     —         5,092,950       —         —    
  

 

 

   

 

 

   

 

 

   

 

 

 

RETAINED EARNINGS, END OF PERIOD

   $ 21,558,508     $ 20,863,976     $ 21,558,508     $ 20,863,976  
  

 

 

   

 

 

   

 

 

   

 

 

 

Per share amounts

        

Net Income (loss) per share

        

Basic

   $ 3.41     $ 0.42     $ (0.04   $ 0.68  

Diluted

   $ 3.40     $ 0.42     $ (0.04   $ 0.68  
  

 

 

   

 

 

   

 

 

   

 

 

 

Dividends

   $ 0.50     $ 0.50     $ 0.00     $ 0.00  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding for the entire period

        

Basic

     631,721       645,485       632,554       646,647  

Diluted

     634,276       648,167       632,554       648,605  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

4


AMERINST INSURANCE GROUP, LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Unaudited, expressed in U.S. dollars)

As of September 30, 2019

 

     Common
Shares
     Additional
Paid-in
Capital
     Retained
Earnings
    Accumulated
Other
Comprehensive
Income (Losses)
    Shares
Held by
Subsidiary
    Total
Shareholders’
Equity
 

BALANCE AT JANUARY 1, 2019

   $ 995,253      $ 6,393,730      $ 19,725,581     $ (218,348   $ (8,941,051   $ 17,955,165  

Net income

     —          —          1,669,711       —         —         1,669,711  

Other comprehensive income

              

Unrealized gains on securities, net of reclassification adjustment

     —          —          —         140,409       —         140,409  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT MARCH 31, 2019

   $ 995,253      $ 6,393,730      $ 21,395,292     $ (77,939   $ (8,941,051   $ 19,765,285  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     —          —          511,444       —         —         511,444  

Issuance of stock option awards

     —          32,266        —         —         —         32,266  

Other comprehensive income

              

Unrealized gain on securities, net of reclassification adjustment

     —          —          —         126,352       —         126,352  

Issuance of shares by subsidiary, net

     —          —          —         —         70,000       70,000  

Dividends ($0.50 per share)

     —          —          (325,691     —         —         (325,691
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT JUNE 30, 2019

   $ 995,253      $ 6,425,996      $ 21,581,045     $ 48,413     $ (8,871,051   $ 20,179,656  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     —          —          (22,537     —         —         (22,537

Issuance of stock option awards

     —          18,040        —         —         —         18,040  

Other comprehensive income

              

Unrealized gain on securities, net of reclassification adjustment

     —          —          —         68,341       —         68,341  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT SEPTEMBER 30, 2019

   $ 995,253      $ 6,444,036      $ 21,558,508     $ 116,754     $ (8,871,051   $ 20,243,500  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

 

 

See the accompanying notes to the unaudited condensed consolidated financial statements

 

5


AMERINST INSURANCE GROUP, LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Unaudited, expressed in U.S. dollars)

As of September 30, 2018

 

     Common
Shares
     Additional
Paid-in
Capital
     Retained
Earnings
    Accumulated
Other
Comprehensive
Income (Losses)
    Shares
Held by
Subsidiary
    Total
Shareholders’
Equity
 

BALANCE AT JANUARY 1, 2018

   $ 995,253      $ 6,323,450      $ 15,812,419     $ 5,029,160     $ (8,454,506   $ 19,705,776  

Net loss

     —          —          (315,167     —         —         (315,167

Other comprehensive loss

              

Unrealized (losses) on securities, net of reclassification adjustment

     —          —          —         (164,192     —         (164,192

Cumulative effect of adoption of accounting guidance (ASU 2016-01))

     —          —          5,092,950       (5,092,950     —         —    
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT MARCH 31, 2018

   $ 995,253      $ 6,323,450      $ 20,590,202     $ (227,982   $ (8,454,506   $ 19,226,417  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     —          —          147,736       —         —         147,736  

Issuance of stock option awards

     —          18,700        —         —         —         18,700  

Other comprehensive loss

              

Unrealized (losses) on securities, net of reclassification adjustment

     —          —          —         (25,186     —         (25,186

Purchase of shares by subsidiary, net

     —          —          —         —         12,542       12,542  

Dividends ($0.50 per share)

     —          —          (313,417     —         —         (313,417
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT JUNE 30, 2018

   $ 995,253      $ 6,342,150      $ 20,424,521     $ (253,168   $ (8,441,964   $ 19,066,792  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     —          —          439,455       —         —         439,455  

Other comprehensive loss

              

Unrealized (losses) on securities, net of reclassification adjustment

     —          —          —         (18,530     —         (18,530
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

BALANCE AT SEPTEMBER 30, 2018

   $ 995,253      $ 6,342,150      $ 20,863,976     $ (271,697   $ (8,441,964   $ 19,487,718  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

6


AMERINST INSURANCE GROUP, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, expressed in U.S. dollars)

 

     Nine Months
Ended
September 30, 2019
    Nine Months
Ended
September 30, 2018
 

OPERATING ACTIVITIES

    

Net Cash provided by Operating Activities

   $ 1,603,447     $ 861,395  
  

 

 

   

 

 

 

INVESTING ACTIVITIES

    

Purchases of property and equipment

     (434,250     (396,674

Purchases of available-for-sale securities

     (5,492,708     (6,035,248

Proceeds from sales of available-for-sale securities

     2,232,592       3,419,578  

Proceeds from redemptions of hedge fund investments

     —         3,085  

Proceeds from redemptions of fixed maturity investments

     265,000       —    

Proceeds from maturities of fixed maturity investments

     3,090,000       2,370,000  
  

 

 

   

 

 

 

Net Cash used in Investing Activities

     (339,366     (639,259
  

 

 

   

 

 

 

FINANCING ACTIVITIES

    

Dividends paid

     (325,691     (313,417
  

 

 

   

 

 

 

Net Cash used in Financing Activities

     (325,691     (313,417
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

     938,390       (91,281

CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD

   $ 5,971,046     $ 5,718,956  
  

 

 

   

 

 

 

CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD

   $ 6,909,436     $ 5,627,675  
  

 

 

   

 

 

 

 

 

 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

7


AMERINST INSURANCE GROUP, LTD.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2019

1. BASIS OF PREPARATION AND CONSOLIDATION

The condensed consolidated financial statements included herein have been prepared by AmerInst Insurance Group, Ltd. (“AmerInst”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). These financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of our financial position and results of operations as of the end of and for the periods presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany transactions and balances have been eliminated on consolidation. These statements are condensed and do not incorporate all the information required under U.S. GAAP to be included in a full set of financial statements. In these notes, the terms “we”, “us”, “our” or the “Company” refer to AmerInst and its subsidiaries. These condensed statements should be read in conjunction with the audited consolidated financial statements at and for the year ended December 31, 2018 and notes thereto, included in AmerInst’s Annual Report on Form 10-K for the year then ended.

New Accounting Pronouncements

New Accounting Standards Adopted in 2019

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, which is codified in Accounting Standards Codification (“ASC”) 842, amending the guidance on the classification, measurement and disclosure of leases for both lessors and lessees. The ASU requires lessees to recognize a right-of-use asset and an offsetting lease liability on the balance sheet and to disclose qualitative and quantitative information about leasing arrangements. Subsequently, in July 2018, the FASB issued ASU 2018-10, which clarifies how to apply certain aspects of ASC 842. The amendments in the ASU address a number of issues in the new leases guidance, including (1) the rate implicit in the lease, (2) impairment of the net investment in the lease, (3) lessee reassessment of lease classification, (4) lessor reassessment of lease term and purchase options, (5) variable payments that depend on an index or rate, and (6) certain transition adjustments.

In July 2018, the FASB also issued ASU 2018-11, which adds a transition option for all entities and a practical expedient only for lessors to ASU 2016-02. The transition option, which we elected on adoption of the guidance, allows entities to choose not to apply the new leases standard in the comparative periods they present in their financial statements in the year of adoption. Under the transition option, entities can instead opt to continue to apply the legacy guidance in ASC 840—Leases, including its disclosure requirements, in the comparative periods presented in the year they adopt the new leases standard. This means that entities that elect this option will only provide annual disclosures for the comparative periods because ASC 840 does not require interim disclosures. Entities that elect this transition option will still be required to adopt the new leases standard using the modified retrospective transition method required by the standard, but they will recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The practical expedient provides lessors with an option to not separate the non-lease components from the associated lease components when certain criteria are met and requires them to account for the combined component in accordance with the revenue recognition standard in ASC 606 if the associated non-lease components are the predominant components.

The Company adopted the new leasing standard and the related amendments on January 1, 2019. The Company believes the most significant change relates to the recognition of new right of use assets and lease liabilities on the consolidated balance sheet for Protexure’s real estate operating lease. These assets and liabilities, which are included in the “Prepaid expenses and other assets “line and “Accrued expenses and other liabilities” line of the Condensed Consolidated Balance Sheets, respectively, represent less than 1% of the Company’s total assets and total liabilities. The adoption did not have a material impact on its consolidated financial statements.

Accounting Standards Not Yet Adopted

Financial Instruments Credit Losses-Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU 2016-13, which amends the guidance on impairment of financial instruments and significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The ASU will replace the existing “incurred loss” approach, with an “expected loss” model for instruments measured at amortized cost and require entities to record allowances for available-for-sale debt securities rather than reduce the carrying amount under the existing other-than temporary-impairment model. The ASU also simplifies the accounting model for purchased credit-impaired debt securities and loans. The tentative effective date for the ASU is January 1, 2023. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.

 

8


Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income

In February 2018, the FASB issued ASU 2018-02 “Income Statement—Reporting Comprehensive Income (Topic 220)—Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” in response to a financial reporting issue that arose as a consequence of the U.S. federal government tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (“U.S. Tax Reform”) which became law on December 22, 2017.

U.S. GAAP currently requires deferred tax liabilities and assets to be adjusted for the effect of a change in tax laws or rates with the effect included in income from continuing operations in the reporting period that includes the enactment date. This guidance is applicable even in situations in which the related income tax effects of items in accumulated other comprehensive income were originally recognized in other comprehensive income rather than in income from continuing operations. As the adjustment of deferred taxes due to the reduction of the historical corporate income tax rate to the newly enacted corporate income tax rate is required to be included in income from continuing operations, the tax effects of items within accumulated other comprehensive income (referred to as stranded tax effects for purposes of this update) do not reflect the appropriate tax rate.

The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. Tax Reform. Consequently, the amendments eliminate the stranded tax effects resulting from U.S. Tax Reform and will improve the usefulness of information reported to financial statement users. However, because the amendments only relate to the reclassification of the income tax effects of U.S. Tax Reform, the underlying guidance that requires the effect of a change in tax laws or rates be included in income from continuing operations is not affected.

Changes to the Disclosure Requirements for Fair Value Measurements

In August 2018, the FASB issued ASU 2018-13, which amended the fair value measurement guidance in ASC 820—Fair Value Measurement, by removing and modifying certain existing disclosure requirements, while also adding new disclosure requirements. The ASU is effective for interim and annual reporting periods beginning after December 15, 2019, although early adoption is permitted, with the amendments being applied either prospectively or retrospectively, as specified in the ASU. In addition, an entity may elect to early adopt the removal or modification of disclosures immediately and delay the adoption of the new disclosure requirements until the effective date. We are currently assessing the impact of adopting this guidance. However, we do not expect the new or modified disclosures to have a material impact on our consolidated financial statements.

 

9


2. INVESTMENTS

The cost or amortized cost, gross unrealized holding gains and losses, and estimated fair value of the Company’s fixed maturity investments, by major security type, and equity securities as of September 30, 2019 and December 31, 2018 are as follows:

 

     Cost or
Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair Value
 

As of September 30, 2019

           

Fixed maturity investments:

           

U.S. government agency securities

   $ 4,524,710      $ 48,329      $ (725    $ 4,572,314  

Obligations of U.S. states and political subdivisions

     2,947,364        32,641        —          2,980,005  

Corporate debt securities

     7,329,613        41,628        (5,119      7,366,122  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total fixed maturity investments

     14,801,687        122,598        (5,844      14,918,441  
  

 

 

    

 

 

    

 

 

    

 

 

 

Equity securities

     12,002,872        4,456,663        (545,302      15,914,233  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total equity securities

     12,002,872        4,456,663        (545,302      15,914,233  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total investments

   $ 26,804,559      $ 4,579,261      $ (551,146    $ 30,832,674  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Cost or
Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair Value
 

As of December 31, 2018

           

Fixed maturity investments:

           

U.S. government agency securities

   $ 6,739,840      $ 287      $ (66,395    $ 6,673,732  

Obligations of U.S. states and political subdivisions

     1,908,719        7,735        (13,514      1,902,940  

Corporate debt securities

     6,157,868        —          (146,460      6,011,408  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total fixed maturity investments

     14,806,427        8,022        (226,369      14,588,080  
  

 

 

    

 

 

    

 

 

    

 

 

 

Equity securities

     12,145,120        2,596,269        (1,296,163      13,445,226  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total equity securities

     12,145,120        2,596,269        (1,296,163      13,445,226  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total investments

   $ 26,951,547      $ 2,604,291      $ (1,522,532    $ 28,033,306  
  

 

 

    

 

 

    

 

 

    

 

 

 

The following tables summarize the Company’s fixed maturity and equity securities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:

 

     12 months or greater     Less than 12 months     Total  
     Estimated
Fair Value
     Unrealized
Losses
    Estimated
Fair Value
     Unrealized
Losses
    Estimated
Fair Value
     Unrealized
Losses
 

As of September 30, 2019

               

Fixed maturity investments:

               

U.S. government agency securities

   $ —        $ —       $ 249,275      $ (725   $ 249,275      $ (725

Obligations of states and political subdivisions

     —          —         —          —         —          —    

Corporate debt securities

     2,125,346        (5,119     —          —         2,125,346        (5,119
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total fixed maturity investments

     2,125,346        (5,119     249,275        (725     2,374,621        (5,844
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Equity securities

     710,251        (357,984     3,013,455        (187,318     3,723,706        (545,302
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total equity securities

     710,251        (357,984     3,013,455        (187,318     3,723,706        (545,302
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total investments

   $ 2,835,597      $ (363,103   $ 3,262,730      $ (188,043   $ 6,098,327      $ (551,146
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

10


     12 months or greater     Less than 12 months     Total  
     Estimated
Fair Value
     Unrealized
Losses
    Estimated
Fair Value
     Unrealized
Losses
    Estimated
Fair Value
     Unrealized
Losses
 

As of December 31, 2018

               

Fixed maturity investments:

               

U.S. government agency securities

   $ 3,389,369      $ (55,015   $ 2,788,235      $ (11,380   $ 6,177,604      $ (66,395

Obligations of states and political subdivisions

     766,118        (13,166     139,651        (348     905,769        (13,514

Corporate debt securities

     4,498,396        (125,689     1,513,012        (20,771     6,011,408        (146,460
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total fixed maturity investments

     8,653,883        (193,870     4,440,898        (32,499     13,094,781        (226,369
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Equity securities

     97,708        (40,981     5,683,065        (1,255,182     5,780,773        (1,296,163
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total equity securities

     97,708        (40,981     5,683,065        (1,255,182     5,780,773        (1,296,163
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total investments

   $ 8,751,591      $ (234,851   $ 10,123,963      $ (1,287,681   $ 18,875,554      $ (1,522,532
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

As of September 30, 2019 and December 31, 2018, there were six and 35 fixed income securities in an unrealized loss position with an estimated fair value of $2,374,621 and $13,094,781, respectively. As of September 30, 2019 and December 31, 2018, five and 21 of these fixed income securities had been in an unrealized loss position for 12 months or greater, respectively. As of September 30, 2019 and December 31, 2018, none of the fixed income securities were considered to be other-than-temporarily impaired. The Company has the intent to hold these fixed income securities, and it is not more likely than not that the Company will be required to sell these fixed income securities before their fair values recover above the adjusted cost. The unrealized losses from these fixed income securities were not a result of credit, collateral or structural issues.

Other-Than-Temporary Impairment Process

The Company assesses whether declines in the fair value of its fixed maturity investments classified as available-for-sale represent impairments that are other-than-temporary by reviewing each fixed maturity investment that is impaired and (1) determining if the Company has the intent to sell the fixed maturity investment or if it is more likely than not that the Company will be required to sell the fixed maturity investment before its anticipated recovery; and (2) assessing whether a credit loss exists, that is, where the Company expects that the present value of the cash flows expected to be collected from the fixed maturity investment are less than the amortized cost basis of the investment.

The Company had no planned sales of its fixed maturity investments classified as available-for-sale that were in an unrealized loss position at September 30, 2019. In assessing whether it is more likely than not that the Company will be required to sell a fixed maturity investment before its anticipated recovery, the Company considers various factors including its future cash flow requirements, legal and regulatory requirements, the level of its cash, cash equivalents, short term investments and fixed maturity investments available for sale in an unrealized gain position, and other relevant factors.

In evaluating credit losses, the Company considers a variety of factors in the assessment of a fixed maturity investment including: (1) the time period during which there has been a significant decline below cost; (2) the extent of the decline below cost and par; (3) the potential for the fixed maturity investment to recover in value; (4) an analysis of the financial condition of the issuer; (5) the rating of the issuer; and (6) failure of the issuer of the fixed maturity investment to make scheduled interest or principal payments.

If we conclude a fixed income investment is other-than-temporarily impaired, we write down the amortized cost of the security to fair value, with a charge to net realized investment gains (losses) in the Consolidated Statement of Operations. Gross unrealized losses on the Company’s fixed maturity investments as of September 30, 2019 and December 31, 2018, relating to six and 35 fixed maturity securities, amounted to $5,844 and $226,369, respectively. The unrealized losses on these available for sale fixed maturity securities were not as a result of credit, collateral or structural issues. During the nine months ended and three months ended September 30, 2019, no other-than-temporary impairment charges were recorded.

 

11


Fair Value of Investments

Under existing U.S. GAAP, we are required to recognize certain assets at their fair value in our consolidated balance sheets. This includes our fixed maturity investments and equity securities. In accordance with the Fair Value Measurements and Disclosures Topic of FASB’s ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon whether the inputs to the valuation of an asset or liability are observable or unobservable in the market at the measurement date, with quoted market prices being the highest level (Level 1) and unobservable inputs being the lowest level (Level 3). A fair value measurement will fall within the level of the hierarchy based on the inputs that are significant to determining such measurement. The three levels are defined as follows:

 

   

Level 1: Observable inputs to the valuation methodology that are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

   

Level 2: Observable inputs to the valuation methodology other than quoted market prices (unadjusted) for identical assets or liabilities in active markets. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

 

   

Level 3: Inputs to the valuation methodology that are unobservable for the asset or liability.

At each measurement date, we estimate the fair value of the security using various valuation techniques. We utilize, to the extent available, quoted market prices in active markets or observable market inputs in estimating the fair value of our investments. When quoted market prices or observable market inputs are not available, we utilize valuation techniques that rely on unobservable inputs to estimate the fair value of investments. The following describes the valuation techniques we used to determine the fair value of investments held as of September 30, 2019 and December 31, 2018 and what level within the fair value hierarchy each valuation technique resides:

 

   

U.S. government agency securities: Comprised primarily of bonds issued by the Federal Home Loan Bank, the Federal Home Loan Mortgage Corporation, Federal Farm Credit Bank and the Federal National Mortgage Association. The fair values of U.S. government agency securities are priced using the spread above the risk-free U.S. Treasury yield curve. As the yields for the risk-free U.S. Treasury yield curve are observable market inputs, the fair values of U.S. government agency securities are classified as Level 2 in the fair value hierarchy. AmerInst considers a liquid market to exist for these types of securities held. Broker quotes are not used for fair value pricing.

 

   

Obligations of state and political subdivisions: Comprised of fixed income obligations of state and local governmental municipalities. The fair values of these securities are based on quotes and current market spread relationships, and are classified as Level 2 in the fair value hierarchy. AmerInst considers a liquid market to exist for these types of securities held. Broker quotes are not used for fair value pricing.

 

   

Corporate debt securities: Comprised of bonds issued by corporations. The fair values of these securities are based on quotes and current market spread relationships, and are classified as Level 2 in the fair value hierarchy. AmerInst considers a liquid market to exist for these types of securities held. Broker quotes are not used for fair value pricing.

 

   

Equity securities, at fair value: Comprised primarily of investments in the common stock of publicly traded companies in the U.S. All of the Company’s equities are classified as Level 1 in the fair value hierarchy. AmerInst receives prices based on closing exchange prices from independent pricing sources to measure fair values for the equities.

While we obtain pricing from independent pricing services, management is ultimately responsible for determining the fair value measurements for all securities. To ensure fair value measurement is applied consistently and in accordance with U.S. GAAP, we periodically update our understanding of the pricing methodologies used by the independent pricing services. We also undertake further analysis with respect to prices we believe may not be representative of fair value under current market conditions. Our review process includes, but is not limited to: (i) initial and ongoing evaluation of the pricing methodologies and valuation models used by outside parties to calculate fair value; (ii) quantitative analysis; (iii) a review of multiple quotes obtained in the pricing process and the range of resulting fair values for each security, if available, and (iv) randomly selecting purchased or sold securities and comparing the executed prices to the fair value estimates provided by the independent pricing sources.

 

12


There have been no material changes to our valuation techniques from what was used as of December 31, 2018. Since the fair value of a security is an estimate of what a willing buyer would pay for such security if we sold it, we cannot know the ultimate value of our securities until they are sold. We believe the valuation techniques utilized provide us with a reasonable estimate of the price that would be received if we were to sell our assets or transfer our liabilities in an orderly market transaction between participants at the measurement date. The following tables show the fair value of the Company’s investments in accordance with ASC 820 as of September 30, 2019 and December 31, 2018:

 

     Carrying
amount
     Total fair
value
     Fair value measurement using:  
     Quoted prices
in active
markets
(Level 1)
     Significant other
observable inputs
(Level 2)
     Significant
unobservable inputs
(Level 3)
 

As of September 30, 2019

              

U.S. government agency securities

   $ 4,572,314      $ 4,572,314      $ —        $ 4,572,314      $ —    

Obligations of U.S. state and political subdivisions

     2,980,005        2,980,005           2,980,005     

Corporate debt securities

     7,366,122        7,366,122           7,366,122     
  

 

 

    

 

 

          

Total fixed maturity investments

     14,918,441        14,918,441           
  

 

 

    

 

 

          

Equity securities

     15,914,233        15,914,233        15,914,233        
  

 

 

    

 

 

          

Total equity securities

     15,914,233        15,914,233           
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total investments

   $ 30,832,674      $ 30,832,674      $ 15,914,233      $ 14,918,441      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Carrying
amount
     Total fair
value
     Fair value measurement using:  
     Quoted prices
in active
markets
(Level 1)
     Significant other
observable inputs
(Level 2)
     Significant
unobservable inputs
(Level 3)
 

As of December 31, 2018

              

U.S. government agency securities

   $ 6,673,732      $ 6,673,732      $ —        $ 6,673,732      $ —    

Obligations of U.S. state and political subdivisions

     1,902,940        1,902,940           1,902,940     

Corporate debt securities

     6,011,408        6,011,408           6,011,408     
  

 

 

    

 

 

          

Total fixed maturity investments

     14,588,080        14,588,080           
  

 

 

    

 

 

          

Equity securities

     13,445,226        13,445,226        13,445,226        
  

 

 

    

 

 

          

Total equity securities

     13,445,226        13,445,226           
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total investments

   $ 28,033,306      $ 28,033,306      $ 13,445,226      $ 14,588,080      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

There were no transfers between Levels 1 and 2 during the nine months ended September 30, 2019 and the year ended December 31, 2018.

 

13


Contractual Maturities

The cost or amortized cost and estimated fair value of fixed maturity investments as of September 30, 2019 and December 31, 2018 by contractual maturity are shown below. Expected maturities may differ from contractual maturities as borrowers may have the right to call or prepay obligations without penalties.

 

     Amortized
Cost
   Estimated
Fair Value

September 30, 2019

         

Due in one year or less

     $ 2,795,026      $ 2,798,831

Due after one year through five years

       11,496,703        11,608,575

Due after five years through ten years

       509,958        511,035
    

 

 

      

 

 

 

Total

     $ 14,801,687      $ 14,918,441
    

 

 

      

 

 

 
     Amortized
Cost
   Estimated
Fair Value

December 31, 2018

         

Due in one year or less

     $ 4,434,013      $ 4,429,510

Due after one year through five years

       9,851,410        9,644,270

Due after five years through ten years

       521,004        514,300
    

 

 

      

 

 

 

Total

     $ 14,806,427      $ 14,588,080
    

 

 

      

 

 

 

Information on sales and maturity of investments and net unrealized gains (losses) on equity investments during the nine months ended September 30, 2019 and 2018 are as follows:

 

     September 30,
2019
   September 30,
2018

Total proceeds from sales of available-for-sale securities

     $ 2,232,592      $ 3,419,578

Proceeds from redemptions of hedge fund investments

       —          3,085

Proceeds from redemptions of fixed maturity investments

       265,000        —  

Total proceeds from maturities of fixed maturity investments

       3,090,000        2,370,000

Gross gains on sales

       570,563        1,448,841

Gross losses on sales

       (586,028 )        (13,983 )

Net unrealized gains (losses) on equity investments

       2,611,254        (539,518 )
    

 

 

      

 

 

 

Total

     $ 2,595,789      $ 895,340
    

 

 

      

 

 

 

Information on sales and maturity of investments and net unrealized gains (losses) on equity investments during the three months ended September 30, 2019 and 2018 are as follows:

 

                         
     September 30,
2019
    September 30,
2018
 

Total proceeds from sales of available-for-sale securities

   $ 429,866     $ 489,440  

Proceeds from redemptions of fixed maturity investments

     265,000       —    

Total proceeds from maturities of fixed maturity investments

     840,000       400,000  

Gross gains on sales

     47,828       135,997  

Gross losses on sales

     (492,424     (13,367

Net unrealized gains on equity investments

     517,088       444,424  
  

 

 

   

 

 

 

Total

   $ 72,492     $ 567,054  
  

 

 

   

 

 

 

 

14


Net Investment Income

Major categories of net investment income during the nine months ended September 30, 2019 and 2018 are summarized as follows:

 

     September 30,
2019
   September 30,
2018

Interest earned:

         

Fixed maturity investments

     $ 263,575      $ 249,287

Short-term investments and cash and cash equivalents

       55,362        10,876

Dividends earned

       138,543        116,432

Investment expenses

       (102,337 )        (108,687 )
    

 

 

      

 

 

 

Net investment income

     $        355,143      $        267,908
    

 

 

      

 

 

 

Major categories of net investment income during the three months ended September 30, 2019 and 2018 are summarized as follows:

 

     September 30,
2019
   September 30,
2018

Interest earned:

         

Fixed maturity investments

     $ 91,690      $ 83,688

Short-term investments and cash and cash equivalents

       19,488        5,287

Dividends earned

       44,571        40,362

Investment expenses

       (30,258 )        (37,122 )
    

 

 

      

 

 

 

Net investment income

     $        125,491      $        92,215
    

 

 

      

 

 

 

3. LIABILITY FOR UNPAID LOSSES AND LOSS ADJUSTMENT EXPENSES

The following table presents a reconciliation of the beginning and ending balances for the liability for unpaid losses and loss adjustment expenses for the nine months ended September 30, 2019 and 2018:

 

     September 30,
2019
   September 30,
2018

Liability—beginning of year

     $ 12,989,260      $ 11,228,507

Incurred related to:

         

Current year

       5,210,575        4,660,077

Prior years

       —          —  
    

 

 

      

 

 

 

Total incurred

       5,210,575        4,660,077
    

 

 

      

 

 

 

Paid related to:

         

Current year

       (94,416 )        (202,620 )

Prior years

       (2,308,016 )        (3,083,995 )
    

 

 

      

 

 

 

Total paid

       (2,402,432 )        (3,286,615 )
    

 

 

      

 

 

 

Liability—end of year

     $   15,797,403      $   12,601,969
    

 

 

      

 

 

 

As incurred losses for the nine months ended September 30, 2019 are derived by multiplying our estimated loss ratio of 64.0% and the net premiums earned, as stated in Results of Operations below, all incurred losses are assumed to be current year losses.

 

15


4. SEGMENT INFORMATION

AmerInst has two reportable segments: (1) reinsurance activity, which also includes investments and other activities, and (2) insurance activity, which offers professional liability solutions to professional service firms under the Agency Agreement with C&F, as defined in the “Overview” section below.

The tables below summarize the results of our reportable segments as of and for the nine months ended September 30, 2019 and 2018.

 

     As of and for the Nine Months Ended September 30, 2019  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 11,053,834      $ 4,434,479      $ 15,488,313  

Total losses and expenses

     9,241,760        4,087,935        13,329,695  

Segment income

     1,812,074        346,544        2,158,618  

Identifiable assets

     —          983,448        983,448  
     As of and for the Nine Months Ended September 30, 2018  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 8,385,269      $ 4,094,462      $ 12,479,731  

Total losses and expenses

     8,318,960        3,888,747        12,207,707  

Segment income

     66,309        205,715        272,024  

Identifiable assets

     —          636,500        636,500  

The tables below summarize the results of our reportable segments as of and for the three months ended September 30, 2019 and 2018.

 

                                                        
     As of and for the Three Months Ended September 30,  2019  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 3,001,278      $ 1,462,989      $ 4,464,267  

Total losses and expenses

     3,120,582        1,366,222        4,486,804  

Segment (loss) income

     (119,304      96,767        (22,537

Identifiable assets

     —          983,448        983,448  
     As of and for the Three Months Ended September 30,  2018  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 3,212,326      $ 1,335,339      $ 4,547,665  

Total losses and expenses

     2,842,754        1,265,456        4,108,210  

Segment income

     369,572        69,883        439,455  

Identifiable assets

     —          636,500        636,500  

5. STOCK COMPENSATION

Phantom Shares:

Protexure Insurance Agency, Inc. (“Protexure”) (formerly AmerInst Professional Services, Limited), a subsidiary of AmerInst, has employment agreements with four key members of senior management, which grant them phantom shares of the Company. Under these agreements, these employees were initially granted an aggregate of 75,018 phantom shares of the Company on the date of their employment, subject to certain vesting requirements. The phantom shares are eligible for phantom dividends payable at the same rate as regular dividends on the Company’s common shares. The phantom dividends may be used only to purchase additional phantom shares with the purchase price of such phantom shares being the net book value of the Company’s actual common shares as of the end of the previous quarter. During the nine months ended September 30, 2019, 1,397 phantom shares were granted, arising from the dividends declared on the Company’s common shares. During the three months ended September 30, 2019, no phantom shares were granted. 89,033 phantom shares were outstanding at September 30, 2019.

 

16


For three of these employees, the phantom shares initially granted, as well as any additional shares granted from dividends declared, vested on January 1, 2015. For the fourth employee, the phantom shares initially granted, as well as any additional shares granted from dividends declared, vested on January 1, 2018. The liability payable to each of these employees under the phantom share agreements is equal to the value of the phantom shares based on the net book value of the Company’s actual common shares at the end of the previous quarter less the value of phantom shares initially granted and is payable in cash upon the earlier of the employee attaining 65 years of age or within 60 days of such employee’s death or permanent disability.

The liability relating to these phantom shares is recalculated quarterly based on the net book value of our common shares at the end of each quarter. As a result of the overall decrease in the net book value of our common shares since the grant dates, we have not recorded any liability relating to these phantom shares at September 30, 2019.

Stock Option Plan:

The Company has a nonqualified stock option plan to advance the development, growth and financial condition of the Company. This plan provides incentives through participation in the appreciation of its common stock in order to secure, retain and motivate directors and employees and align such person’s interests with those of its shareholders. A total of 100,000 shares are authorized under the stock option plan.

A summary of the status of the stock option plan as of September 30, 2019 is as follows:

 

     Vested
Shares
     Weighted
Average
Exercise
Price Per
Share
     Non-vested
Shares
    Weighted
Average
Exercise
Price Per
Share
     Total
Shares
     Weighted
Average
Exercise
Price Per
Share
 

Outstanding—January 1, 2019

     7,000      $ 27.99        40,000     $ 28.71        47,000      $ 28.60  

Granted

     —          —          —         —          —          —    

Forfeited

     —          —          —         —          —          —    

Exercised

     —          —          —         —          —          —    

Vested

     8,400        28.42        (8,400     28.42        —          —    

Outstanding—September 30, 2019

     15,400      $ 28.23        31,600     $ 28.79        47,000      $ 28.60  

Options exercisable at year end

     —          —          —         —          —          —    

Weighted average fair value of options per share granted during the year

     —          —        $ —         —        $ —          —    

Remaining contractual life (years)

     3.3           3.7          3.6     

A summary of the status of the stock option plan as of December 31, 2018 is as follows:

 

     Vested
Shares
     Weighted
Average
Exercise
Price Per
Share
     Non-vested
Shares
    Weighted
Average
Exercise
Price Per
Share
     Total
Shares
     Weighted
Average
Exercise
Price Per
Share
 

Outstanding—January 1, 2018

     —          —          35,000     $ 27.99        35,000      $ 27.99  

Granted

     —          —          12,000       30.40        12,000        30.40  

Forfeited

     —          —          —         —          —          —    

Exercised

     —          —          —         —          —          —    

Vested

     7,000        27.99        (7,000     27.99        —          —    

Outstanding—December 31, 2018

     7,000      $ 27.99        40,000     $ 28.71        47,000      $ 28.60  

Options exercisable at year end

     —          —          —         —          —          —    

Weighted average fair value of options per share granted during the year

     —          —        $ —         —        $ —          —    

Remaining contractual life (years)

     4.0           4.4          4.4     

The Company accounts for these options in accordance with GAAP, which requires that the fair value of the equity awards be recognized as compensation expense over the period during which the employee is required to provide service in exchange for such an award. The Company is amortizing compensation expense over the vesting period of five years. The Company recognized $50,306 and $70,280 of compensation expense for stock options for the nine months ended September 30, 2019 and for the year ended December 31, 2018, respectively.

 

17


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Management’s discussion and analysis (“MD&A”) provides supplemental information, which sets forth the major factors that have affected our financial condition and results of operation and should be read in conjunction with our condensed consolidated financial statements and notes thereto included in this Form 10-Q.

Certain statements contained in this Form 10-Q, including this MD&A section, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and contain information relating to us that is based on the beliefs of our management as well as assumptions made by, and information currently available to, our management. The words “expect,” “believe,” “may,” “could,” “should,” “would,” “estimate,” “anticipate,” “intend,” “plan,” “target,” “goal” and similar expressions as they relate to us or our management are intended to identify forward-looking statements.

All forward-looking statements, by their nature, are subject to risks and uncertainties. Our actual future results may differ materially from those set forth in our forward-looking statements. Please see the Introductory Note and Item 1A “Risk Factors” of our 2018 Annual Report on Form 10-K, as updated in our subsequent quarterly reports filed on Form 10-Q, and in our other filings made from time to time with the Commission after the date of this report for a discussion of factors that could cause our actual results to differ materially from those in the forward-looking statements. However, the risk factors listed in Item 1A “Risk Factors” of our 2018 Annual Report on Form 10-K or discussed in this Quarterly Report on Form 10-Q should not be construed as exhaustive and should be read in conjunction with other cautionary statements that are included herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect our management’s analysis only as of the date they are made. We undertake no obligation to release publicly the results of any future revisions we may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

The following discussion addresses our financial condition and results of operations for the periods and as of the dates indicated.

OVERVIEW

Unless otherwise indicated by the context in this quarterly report, we refer to AmerInst Insurance Group, Ltd. and its subsidiaries as the “Company,” “AmerInst,” “we” or “us.” “AMIC Ltd.” means AmerInst’s wholly owned subsidiary, AmerInst Insurance Company, Ltd. “Protexure” means Protexure Insurance Agency, Inc., a Delaware corporation and wholly owned subsidiary of AmerInst Mezco, Ltd. which is a wholly owned subsidiary of AmerInst. “Investco” means AmerInst Investment Company, Ltd., a wholly owned subsidiary of AMIC Ltd. Our principal offices are c/o Citadel Management Bermuda Limited, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, Bermuda, HM GX.

AmerInst Insurance Group, Ltd. is a Bermuda holding company formed in 1998 that provides insurance protection for professional service firms and engages in investment activities. AmerInst has two reportable segments: (1) reinsurance activity, which includes investments and other activities, and (2) insurance activity, which offers professional liability solutions to professional service firms. The revenues of the reinsurance activity reportable segment and the insurance activity reportable segment were $11,053,834 and $4,434,479, respectively, for the nine months ended September 30, 2019 compared to $8,385,269 and $4,094,462, respectively, for the nine months ended September 30, 2018. The revenues for both reportable segments were derived from business operations in the United States other than interest income on bank accounts maintained in Bermuda.

Entry into Agency Agreement

On September 25, 2009, Protexure entered into an agency agreement (the “Agency Agreement”) with The North River Insurance Company, United States Fire Insurance Company, Crum & Forster Indemnity Company, Crum and Forster Insurance Company, and Crum & Forster Specialty Insurance Company (collectively, “C&F”) pursuant to which C&F appointed Protexure as its exclusive agent for the purposes of soliciting, underwriting, quoting, binding, issuing, cancelling, non-renewing and endorsing accountants’ professional liability and lawyers’ professional liability insurance coverage in all 50 states of the United States and the District of Columbia. The initial term of the Agency Agreement was for four years with automatic one-year renewals thereafter. The Agency Agreement automatically renewed on September 25, 2019.

 

18


Entry into Reinsurance Agreement

We conduct our reinsurance business through AMIC Ltd., our subsidiary, which is a registered insurer in Bermuda. On September 25, 2009, AMIC Ltd. entered into a professional liability quota share agreement with C&F (the “Reinsurance Agreement”) pursuant to which C&F agreed to cede, and AMIC Ltd. agreed to accept as reinsurance, a 50% quota share of C&F’s liability under insurance written by Protexure on behalf of C&F and classified by C&F as accountants’ professional liability and lawyers’ professional liability, subject to AMIC Ltd.’s surplus limitations. The term of the Reinsurance Agreement is indefinite and may be terminated by either party upon at least 120 days’ prior written notice to the other party.

Third-party Managers and Service Providers

Citadel Management Bermuda Limited (formerly Cedar Management Limited) provides the day-to-day services necessary for the administration of our business. Our agreement with Citadel Management Bermuda Limited renewed for one year beginning January 1, 2019 and ending December 31, 2019. Mr. Thomas R. McMahon, our Treasurer and Chief Financial Officer, is a shareholder, officer, director and employee of Citadel Management Bermuda Limited. Mr. Stuart Grayston, our President, was formerly a director and officer of Cedar Management Limited.

The Country Club Bank of Kansas City, Missouri, provides portfolio management of fixed-income securities and directs our investments pursuant to guidelines approved by us. Harris Associates L.P. and Tower Wealth Managers, Inc. provide discretionary investment advice with respect to our equity investments. We have retained Oliver Wyman, an independent casualty actuarial consulting firm, to render advice regarding actuarial matters.

RESULTS OF OPERATIONS

Nine months ended September 30, 2019 compared to nine months ended September 30, 2018

We recorded net income of $2,158,618 for the nine months ended September 30, 2019 compared to net income of $272,024 for the same period in 2018. The increase in net income was mainly attributable to the increase in net realized and unrealized gains on investments of $1,700,449 (from $895,340 for the nine months ended September 30, 2018 to $2,595,789 for the nine months ended September 30, 2019) and to the increase in commission income of $304,294 (from $4,091,561 for the nine months ended September 30, 2018 to $4,395,855 for the nine months ended September 30, 2019) as a result of a higher volume of premiums written under the Agency Agreement. This was partially offset by the increase in operating and management expenses of $264,117 (from $4,874,487 for the nine months ended September 30, 2018 to $5,138,604 for the nine months ended September 30, 2019), as discussed in further detail below.

Our net premiums earned for the nine months ended September 30, 2019 were $8,141,526 compared to $7,224,922 for the nine months ended September 30, 2018, an increase of $916,604 or 12.7%. The net premiums earned for the nine months ended September 30, 2019 and 2018 were attributable to cessions from C&F under the Reinsurance Agreement. The increase in net premiums earned under the Reinsurance Agreement during the first nine months of 2019 compared to the same period in 2018 resulted from increased cessions from C&F in 2019, arising from a higher level of underwriting activity under the Agency Agreement due to the continued marketing of the program by Protexure which resulted in greater penetration in targeted markets.

During the nine months ended September 30, 2019 and 2018, we recorded commission income under the Agency Agreement of $4,395,855 and $4,091,561, respectively, an increase of $304,294 or 7.4%. This increase resulted from a higher volume of premiums written under the Agency Agreement in 2019 due to the continued marketing of the program by Protexure which resulted in greater penetration in the targeted markets.

We recorded net investment income of $355,143 for the nine months ended September 30, 2019 compared to $267,908 for the nine months ended September 30, 2018. The increase in net investment income was attributable to higher yielding fixed income securities held in the Company’s investment portfolio during the first nine months of 2019 compared to the same period in 2018 and to certain higher yielding equity securities held in our investment portfolio during the first nine months of 2019 compared to the same period in 2018. The annualized investment yield, calculated as total interest and dividends divided by the net average amount of total investments and cash and cash equivalents, was 1.3% for the nine months ended September 30, 2019, compared to the 1.0% yield earned for the nine months ended September 30, 2018.

We recorded net realized and unrealized gains on investments of $2,595,789 during the nine months ended September 30, 2019 compared to net realized gains of $895,340 during the nine months ended September 30, 2018, an increase of $1,700,449 or 189.9%. The increase was primarily related to the increase in the fair value of our equity investments of $2,611,254 during the first nine months ended September 30, 2019, which was attributable to favorable market conditions.

 

19


For the nine months ended September 30, 2019, we recorded loss and loss adjustment expenses of $5,210,575 derived by multiplying our estimated loss ratio of 64.0% and the net premiums earned under the Reinsurance Agreement of $8,141,526. For the nine months ended September 30, 2018, we recorded loss and loss adjustment expenses of $4,660,077 derived by multiplying our estimated loss ratio of 64.5% and the net premiums earned under the Reinsurance Agreement of $7,224,922. The increase in loss and loss adjustment expense was primarily due to an increase in net premiums earned during the first nine months of 2019 compared to the corresponding period in 2018, partially offset by a reduction of our estimated loss ratio. The decrease in the estimated loss ratio was primarily the result of better than expected loss emergence in accident years 2015 and 2016.

We recorded policy acquisition costs of $3,012,548 for the nine months ended September 30, 2019 compared to $2,673,143 for the same period in 2018. Policy acquisition costs, which are primarily ceding commissions paid to the ceding insurer, are established as a percentage of premiums earned. Therefore, any increase or decrease in premiums earned will result in a similar increase or decrease in policy acquisition costs. The policy acquisition costs recorded during the nine months ended September 30, 2019 and 2018 were 37% of the net premiums earned under the Reinsurance Agreement of $8,141,526 and $7,224,922, respectively.

We expensed operating and management expenses of $5,138,604 for the nine months ended September 30, 2019 compared to $4,874,487 for the same period in 2018, an increase of $264,117 or 5.4%. The increase was primarily attributable to increased salaries and related costs associated with Protexure’s hiring of additional personnel during 2019 and the last three months of 2018.

We recorded an income tax benefit of $32,032 for the nine months ended September 30, 2019 compared to $0 for the same period in 2018. At December 31, 2018, management believed there was sufficient evidence to support the reversal of the full valuation allowance against Protexure’s deferred tax assets. The release of this allowance resulted in the recognition of Protexure’s deferred tax assets and to the recording of income tax benefits.

The tables below summarize the results of the following AmerInst reportable segments: (1) reinsurance activity, which also includes investments and other activities, and (2) insurance activity, which offers professional liability solutions to professional service firms under the Agency Agreement with C&F.

 

     As of and for the Nine Months Ended September 30, 2019  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 11,053,834      $ 4,434,479      $ 15,488,313  

Total losses and expenses

     9,241,760        4,087,935        13,329,695  

Segment income

     1,812,074        346,544        2,158,618  

Identifiable assets

     —          983,448        983,448  
     As of and for the Nine Months Ended September 30, 2018  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 8,385,269      $ 4,094,462      $ 12,479,731  

Total losses and expenses

     8,318,960        3,888,747        12,207,707  

Segment income

     66,309        205,715        272,024  

Identifiable assets

     —          636,500        636,500  

Three months ended September 30, 2019 compared to three months ended September 30, 2018

We recorded a net loss of $22,537 for the three months ended September 30, 2019 compared to net income of $439,455 for the same period in 2018. The decrease in net income was mainly attributable to the decrease in net realized and unrealized gains on investments of $494,562 (from a $567,054 gain for the three months ended September 30, 2018 to a $72,492 gain for the three months ended September 30, 2019) and to the increase in operating and management expenses of $120,219 (from $1,515,854 for the three months ended September 30, 2018 to $1,636,073 for the three months ended September 30, 2019), as discussed in further detail below. The decrease was partially offset by the increase in commission income of $116,015 (from $1,334,352 for the three months ended September 30, 2018 to $1,450,367 for the three months ended September 30, 2019) as a result of a higher volume of premiums written under the Agency Agreement.

Our net premiums earned for the third quarter of 2019 were $2,815,917 compared to $2,554,044 for the third quarter of 2018, an increase of $261,873 or 10.3%. The net premiums earned during the quarters ended September 30, 2019 and 2018 were attributable to cessions from C&F under the Reinsurance Agreement. The increased cessions arose from a higher level of underwriting activity under the Agency Agreement due to the continued marketing of the program by Protexure, which resulted in increased penetration in targeted markets.

 

20


For the quarters ended September 30, 2019 and 2018, we recorded commission income under the Agency Agreement of $1,450,367 and $1,334,352, respectively, an increase of $116,015 or 8.7%. This increase resulted from a higher volume of premiums written under the Agency Agreement in 2019, as referred to above.

We recorded net investment income of $125,491 for the quarter ended September 30, 2019 compared to $92,215 for the quarter ended September 30, 2018. The increase in net investment income was attributable to higher yielding fixed income securities held in the Company’s investment portfolio during the third quarter of 2019 compared to the same period in 2018 and to certain higher yielding equity securities held in our investment portfolio during the third quarter of 2019 compared to the same period in 2018. The annualized investment yield, calculated as total interest and dividends divided by the net average amount of total investments and cash and cash equivalents, was 1.3% for the quarter ended September 30, 2019, compared to the 1.0% yield earned for the quarter ended September 30, 2018.

We recorded net realized and unrealized gains on investments of $72,492 during the quarter ended September 30, 2019 compared to net realized and unrealized gains of $567,054 during the quarter ended September 30, 2018, a decrease of $494,562 or 87.2%. The decrease was primarily related to a loss realized during the quarter ended September 30, 2019 associated with the sale of a certain equity security whose recovery was deemed to be remote.

For the quarter ended September 30, 2019, we recorded loss and loss adjustment expenses of $1,802,187 derived by multiplying our estimated loss ratio of 64.0% and the net premiums earned under the Reinsurance Agreement of $2,815,917. For the quarter ended September 30, 2018, we recorded loss and loss adjustment expenses of $1,647,362 derived by multiplying our estimated loss ratio of 64.5% and the net premiums earned under the Reinsurance Agreement of $2,554,044. The increase in loss and loss adjustment expense was primarily due to an increase in net premiums earned during the quarter ended September 30, 2019 compared to the corresponding period in 2018, partially offset by a reduction of our estimated loss ratio. The decrease in the estimated loss ratio was primarily the result of better than expected loss emergence in accident years 2015 and 2016.

We recorded policy acquisition costs of $1,041,890 in the third quarter of 2019 compared to $944,994 for the same period in 2018. Policy acquisition costs, which are primarily ceding commissions paid to the ceding insurer, are established as a percentage of premiums earned. Therefore, any increase or decrease in premiums earned will result in a similar increase or decrease in policy acquisition costs. The policy acquisition costs recorded during the third quarter of 2019 and 2018 were 37% of the net premiums earned under the Reinsurance Agreement of $2,815,917 and $2,554,044, respectively.

We incurred operating and management expenses of $1,636,073 in the third quarter 2019 compared to $1,515,854 for the same period in 2018, an increase of $120,219 or 7.9%. The increase was primarily attributable to increased salaries and related costs associated with Protexure’s hiring of additional personnel during 2019.

We recorded a negative $6,654 adjustment to our income tax benefit for the quarter ended September 30, 2019 compared to $0 for the same period in 2018. At December 31, 2018, management believed there was sufficient evidence to support the reversal of the full valuation allowance against Protexure’s deferred tax assets. The release of this allowance has resulted in the recognition of Protexure’s deferred tax assets.

The tables below summarize the results of the following AmerInst reportable segments: (1) reinsurance activity, which also includes investments and other activities, and (2) insurance activity, which offers professional liability solutions to professional service firms under the Agency Agreement with C&F.

 

     As of and for the Three Months Ended September 30, 2019  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 3,001,278      $ 1,462,989      $ 4,464,267  

Total losses and expenses

     3,120,582        1,366,222        4,486,804  

Segment (loss) income

     (119,304      96,767        (22,537

Identifiable assets

     —          983,448        983,448  
     As of and for the Three Months Ended September 30, 2018  
     Reinsurance
Segment
     Insurance
Segment
     Total  

Revenues

   $ 3,212,326      $ 1,335,339      $ 4,547,665  

Total losses and expenses

     2,842,754        1,265,456        4,108,210  

Segment income

     369,572        69,883        439,455  

Identifiable assets

     —          636,500        636,500  

 

21


FINANCIAL CONDITION

As of September 30, 2019, our total investments were $30,832,674, an increase of $2,799,368 or 10%, from $28,033,306 at December 31, 2018. This increase was primarily due to the increase in the fair value of certain equity securities as a result of favorable market conditions. The cash and cash equivalents balance increased from $5,498,914 at December 31, 2018 to $5,978,562 at September 30, 2019, an increase of $479,648 or 8.7%. The amount of cash and cash equivalents varies depending on the maturities of fixed term investments and the level of funds invested in money market funds. The restricted cash and cash equivalents balance increased from $472,132 at December 31, 2018 to $930,874 at September 30, 2019, an increase of $458,742 or 97.2%. The increase was due to the timing of sales and maturities of investments held as restricted cash at September 30, 2019 that have not been reinvested. The ratio of cash, total investments and other invested assets to total liabilities at September 30, 2019 was 1.33:1, compared to a ratio of 1.30:1 at December 31, 2018.

The assumed reinsurance balances receivable represents the current assumed premiums receivable from the fronting carriers. As of September 30, 2019, the balance was $2,886,098 compared to $2,651,683 as of December 31, 2018. The increase resulted from a higher level of premiums assumed under the Reinsurance Agreement during 2019.

The assumed reinsurance payable represents current reinsurance losses payable and commissions payable to the fronting carriers. As of September 30, 2019, the balance was $1,077,067 compared to $2,171,767 as of December 31, 2018. This balance fluctuates due to the timing of losses reported to us.

Deferred policy acquisition costs, which represent the deferral of ceding commission expense related to premiums not yet earned, increased from $1,869,368 at December 31, 2018 to $2,111,128 at September 30, 2019. The increase in deferred policy acquisition costs in 2019 was due to the increase in both net premiums written and unearned premiums assumed under the Reinsurance Agreement compared to the prior year. The ceding commission rate under the Reinsurance Agreement is 37%.

Prepaid expenses and other assets were $1,974,296 at September 30, 2019 compared to $1,981,913 as of December 31, 2018. The balance primarily relates to (1) prepaid directors’ and officers’ liability insurance costs, (2) the directors’ prepaid annual retainer, (3) prepaid professional fees and (4) premiums due to Protexure under the Agency Agreement. This balance fluctuates due to the timing of the prepayments and to the timing of the premium receipts by Protexure.

Accrued expenses and other liabilities primarily represent premiums payable by Protexure to C&F under the Agency Agreement and expenses accrued relating largely to professional fees. The balance decreased from $5,934,408 at December 31, 2018 to $5,764,045 at September 30, 2019, a decrease of $170,363 or 2.9%. This balance fluctuates due to the timing of the premium payments to C&F and payments of professional fees.

LIQUIDITY AND CAPITAL RESOURCES

Our cash needs consist of settlement of losses and expenses under our reinsurance treaties and funding day-to-day operations. In continuing the implementation of our business plan, our management expects to meet these cash needs from cash flows arising from our investment portfolio. Because substantially all of our assets are marketable securities, we expect that we will have sufficient flexibility to provide for unbudgeted cash needs that may arise from time to time without resorting to borrowing, subject to Bermuda statutory limitations as discussed in our 2018 Form 10-K.

Total cash, investments and other invested assets increased from $34,004,352 at December 31, 2018 to $37,742,110 at September 30, 2019, an increase of $3,737,758 or 11%. The net increase resulted primarily from favorable market conditions and positive cash inflows derived from net investment activities and net premiums received under the Reinsurance Agreement in the amount of $1.809,731.

The Bermuda Monetary Authority has authorized Investco to purchase our common shares, on a negotiated basis, from shareholders who have died or retired from the practice of public accounting. During the nine months ended September 30, 2019, no such transactions occurred. From inception through September 30, 2019, Investco had repurchased 217,661 common shares from shareholders who had died or retired for a total purchase price of $6,186,730. From time to time, Investco has also purchased shares in privately negotiated transactions. From inception through September 30, 2019, Investco had purchased an additional 75,069 common shares in such privately negotiated transactions for a total purchase price of $1,109,025. During the nine months ended September 30, 2019, no such transactions occurred.

 

22


Cash Dividends

During the second quarter of 2019, we declared a dividend of $0.50 per share to be paid to our shareholders on or before December 1, 2019, which amounted to total ordinary cash dividends of $352,459. The dividends to be paid in 2019 have been reduced by $26,768, which represents a write-back of uncashed dividends issued prior to 2014 to shareholders that we have been unable to locate. Since we began paying dividends in 1995, our original shareholders have received $22.87 in cumulative dividends per share. When measured by a total rate of return calculation, this has resulted in an effective annual rate of return of approximately 8.6% from our inception, based on a per share purchase price of $8.33 paid by the original shareholders, and using an unaudited net book value of $32.00 per share as of September 30, 2019. Although we have paid cash dividends on a regular basis in the past, the declaration and payment of cash dividends in the future will be at the discretion of our board of directors, subject to the requirements of applicable law, and will depend on, among other things, our financial condition, results of operations, current and anticipated cash needs and other factors that our board of directors considers relevant.

OFF-BALANCE SHEET ARRANGEMENTS

The Company is not a party to any off-balance sheet arrangements.

CRITICAL ACCOUNTING POLICIES

Our critical accounting policies are discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and is incorporated herein by reference.

We have identified accounting for the liability for losses and loss adjustment expenses as our most critical accounting policy and estimate in that it is important to the portrayal of our financial condition and results, and it requires our subjective and complex judgment as a result of the need to make estimates about the effects of matters that are inherently uncertain. This accounting policy, including the nature of the estimates and types of assumptions used, are described throughout this Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2018.

Available Information

We file annual, quarterly, and current reports, proxy statements and other information with the Commission. You may read any public document we file with the Commission at the Commission’s public reference room at 100 F Street, NE, Washington, DC 20549. Please call the Commission at 1-800-SEC-0330 for information on the public reference room. The Commission maintains an internet site that contains annual, quarterly, and current reports, proxy and information statements and other information that issuers (including AmerInst) file electronically with the Commission. The Commission’s internet site is www.sec.gov.

Our internet site is www.amerinst.bm. We make available free of charge through our internet site our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Commission. We also make available, through our internet site, via links to the Commission’s internet site, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Securities Exchange Act. In addition, we post on www.amerinst.bm our Memorandum of Association, our Bye-Laws, our Statement of Share Ownership Policy, Charters for our Audit Committee and Governance and Nominations Committee, as well as our Code of Business Conduct and Ethics. You can request a copy of these documents, excluding exhibits, at no cost, by writing or telephoning us c/o Citadel Management Bermuda Limited, 25 Church Street, Continental Building, P.O. Box HM 1601 Hamilton, Bermuda HM GX, Attention: Investor Relations (441) 295-6015. The information on our internet site is not incorporated by reference into this report.

 

23


Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

 

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of September 30, 2019, the end of the period covered by this Form 10-Q, our management, including our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer each concluded that as of September 30, 2019, the end of the period covered by this Form 10-Q, we maintained effective disclosure controls and procedures.

Changes in Internal Control over Financial Reporting

Our management, including our Principal Executive Officer and Principal Financial Officer, has reviewed our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934). There have been no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II—OTHER INFORMATION

 

Item 1.

Legal Proceedings

We are party to various legal proceedings generally arising in the normal course of our business. While any proceeding contains an element of uncertainty, we do not believe that the eventual outcome of any litigation or arbitration proceeding to which we are presently a party will have a material adverse effect on our financial condition or business. Pursuant to our insurance and reinsurance agreements, disputes are generally required to be finally settled by arbitration.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our 2018 Annual Report on Form 10-K, as updated in our subsequent quarterly reports. The risks described in our 2018 Annual Report on Form 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

 

Item 3.

Defaults Upon Senior Securities.

None.

 

Item 4.

Mine Safety Disclosures

Not applicable.

 

Item 5.

Other Information

None.

 

24


Item 6.

Exhibits

(a) Exhibits

 

Exhibit

Number

  

Description

  31.1    Certification of Stuart H. Grayston pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2    Certification of Thomas R. McMahon pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1    Certification of Stuart H. Grayston pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2    Certification of Thomas R. McMahon pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document
101.SCH    XBRL Taxonomy Extension Schema Document
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB    XBRL Taxonomy Extension Label Linkbase Document
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document

 

25


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 13, 2019   AMERINST INSURANCE GROUP, LTD.
 

(Registrant)

 

By:

 

/s/ STUART H. GRAYSTON

   

Stuart H. Grayston

    President (Principal Executive Officer, duly authorized to sign this Report in such capacity and on behalf of the Registrant)
 

By:

 

/s/ THOMAS R. MCMAHON

   

Thomas R. McMahon

    Chief Financial Officer (Principal Financial Officer, duly authorized to sign this Report in such capacity and on behalf of the Registrant)

 

26


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
1/1/23
12/31/1910-K
12/15/19
12/1/19
Filed on:11/13/19
11/1/19
For Period end:9/30/19
9/25/19
6/30/1910-Q
3/31/1910-Q
1/1/19
12/31/1810-K,  5
9/30/1810-Q
6/30/1810-Q
3/31/1810-Q
1/1/184
12/22/17
1/1/15
9/25/098-K
 List all Filings 
Top
Filing Submission 0001193125-19-291100   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 6:48:35.5pm ET